🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Application of Chain Management Based on the IMB Model in Patients With Kinesiophobia Following Lumbar Fusion Surgery

RecruitingNAAges 18 Years - 65 YearsAllJiawei Jiang
NCT07883785 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to investigate the application effect of chain management based on the Information-Motivation-Behavioral Skills (IMB) model in patients with kinesiophobia after lumbar fusion surgery. The intervention is designed to provide IMB model-based chain management, with routine nursing intervention as the control, and to evaluate the degree of kinesiophobia (TSK), pain intensity (NRS), lumbar function (ODI), and spinal posture indicators (trunk deviation angle, pelvic torsion angle, and the sum of the maximum left and right vertebral rotation angles) at different time points before and after the intervention. The ultimate objectives are to reduce the level of kinesiophobia, relieve pain, improve lumbar stability and lumbar function, and promote postoperative rehabilitation in patients after lumbar fusion surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Confirmed diagnosis of degenerative spinal disease * First-time treatment with posterior lumbar decompression and interbody fusion, with stable vital signs after surgery * Age ≥18 years * TSK (Tampa Scale of Kinesiophobia) score \>37 within 48 h after surgery Exclusion Criteria: * Concomitant other lumbar spine-related medical history and inability to perform functional exercises * Malignancy or concomitant damage to important organs such as the brain, heart, and lungs * Cognitive impairment
💊

What it tests

  • Basic Postoperative Care
  • chain management based on the Information-Motivation-Behavioral Skills model
📍

Where

1 site
Affiliated 2 Hospital of Nantong University, Nantong, Jiangsu 0513
Nantong, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy